Thalidomide-O-amido-PEG2-C2-NH2 Catalog No.:M13512-10 Check for active clinical trials

Check for active clinical trials or closed clinical trials using this agent

is a polyanionic beta-cyclodextrin derivative with a sodium sulfonate salt separated from the lipophilic cavity by a butyl ether spacer group

AT-rich double-stranded DNA strands enhance fluorescence considerably

AM095 is a potent LPA1 receptor antagonist because it inhibited GTPγS binding to Chinese hamster ovary (CHO) cell membranes overexpressing recombinant human or mouse LPA1 with IC50 values of 0

centrosomal fragmentation induced by Poloxin is partially attributable to dysfunctional Kizuna

Thalidomide-O-amido-PEG2-C2-NH2 Catalog No.:M13512-10 Check for active clinical trialsThalidomide O amido PEG2 C2 NH2 incorporates an E3 ligase ligand and a linker, can be an immunomodulater for the treatment of cancer. Product information CAS Number: 1957235 74 3 Molecular Weight: 462. 45 Formula: C21H26N4O8 Chemical Name: N {2 [2 (2 aminoethoxy)ethoxy]ethyl} 2 {[2 (2,6 dioxopiperidin 3 yl) 1,3 dioxo 2,3 dihydro 1H isoindol 4 yl]oxy}acetamide Smiles: NCCOCCOCCNC(=O)COC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O InChiKey: YNVIHPPEIRQPOL